Alivus Life Sciences Limited has submitted a regulatory disclosure to BSE Ltd. and the National Stock Exchange of India Ltd. pursuant to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
The disclosure intimates about an upcoming Investor/Analyst meeting that will be attended by company representatives. The meeting is scheduled for June 09, 2026, and will be conducted in-person in Mumbai. The type of meeting is specified as "Group/One on One."
The following institutional participants are listed to attend the meeting:
- Alchemy
- ASK Mutual
- Bharti AXA Life Insurance
- HSBC AM
- JM Financial
- Julius Baer
- Lion Global, SG
- Mahindra Manulife
- Ninety One, LDN
- Premji Invest
- Samena
- SBI MF
- Value Partners, HK
The disclosure includes a note that the schedule and mode of meeting may undergo changes due to exigencies on the part of the Investor, Analyst, or the Company.